AstraZeneca PLCAZN:LSE

6.00 / 0.13%
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Apr 01 2015 15:12 BST.


As of last trade AstraZeneca PLC (AZN:LSE) traded at 4,632.5, 6.35 % below its 52-week high of 4,946.41, set on May 02, 2014.

52-week range
Apr 15 2014
May 02 2014
Markit short selling activity
Day high4,677.5
Day low4,602
Previous close4,626.5
Average volume2.74m
Shares outstanding1.26bn
Free float1.26bn
P/E (TTM)70.21
Market cap58.41bn GBP
EPS (TTM)0.6586 GBP
Annual div (IAD)178.10 GBX
Annual div yield (IAD)3.77%
Div ex-dateFeb 19 2015
Div pay-dateMar 23 2015
Data delayed at least 15 minutes, as of Apr 01 2015 15:12 BST.
Last IC View
The last IC recommendation on AstraZeneca PLC shares was Hold at 4,413 on 31 Oct 2014
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AstraZeneca PLC-2.64 %+3.73 %+6.32 %+18.13 %+57.37 %
FTSE 100 IDX-2.59 %-1.97 %+3.85 %+2.36 %+18.54 %
GB/HEALTH CARE-3.83 %+2.58 %+6.53 %+13.06 %+35.41 %
GB/PHARMACEUTICALS-4.03 %+2.97 %+6.35 %+12.68 %+35.00 %
Data delayed at least 15 minutes, as of Apr 01 2015 15:12 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.